Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

Join Channel
Consolidated Standalone

FDC

₹440 -4.8 | 1.1%

Market Cap ₹7163 Cr.

Stock P/E 25.0

P/B 3.5

Current Price ₹440

Book Value ₹ 126

Face Value 1

52W High ₹487.5

Dividend Yield 0%

52W Low ₹ 281.4

Edit Ratio

FDC Research see more...

Overview Inc. Year: 1940Industry: Pharmaceuticals & Drugs

FDC Limited is an India-based company, that's principally engaged within the commercial enterprise of prescription drugs. The Company manufactures and distributes its range of generics, formulations and active prescription drugs at its manufacturing plants. It additionally manufactures oral rehydration salts (ORS) and specialised formulations. It has various functional foods and liquids. Its active pharmaceutical elements (APIs) comprises Albuterol Sulfate, Bromhexine Hydrochloride, Cinnarizine, Flunarizine Dihydrochloride, Flurbiprofen, Flurbiprofen Sodium, Miconazole Nitrate and Timolol Maleate, amongst others. It has its presence in numerous therapeutic segments, including anti-infectives, gastrointestinal, ophthalmological, nutrients/ minerals/ dietary supplements, cardiac, anti-diabetes, respiratory, gynaecology, dermatology, analgesics and others. Its various manufacturers consists of Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl and Mycoderm.

Read More..

FDC Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

FDC Quarterly Results

#(Fig in Cr.) Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 398 342 341 495 445 409 435 536 486 458
Other Income 30 13 10 19 13 18 7 29 27 25
Total Income 428 355 351 514 458 428 442 566 514 483
Total Expenditure 326 294 322 417 378 360 386 414 410 374
Operating Profit 102 61 29 97 80 68 56 151 104 108
Interest 1 1 1 1 1 1 1 1 1 1
Depreciation 9 9 9 9 10 10 10 10 10 10
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 91 51 19 87 69 57 45 141 93 98
Provision for Tax 19 15 9 16 17 16 14 31 23 18
Profit After Tax 72 36 10 71 52 41 31 110 70 79
Adjustments 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 72 36 10 71 52 41 31 110 70 79
Adjusted Earnings Per Share 4.3 2.1 0.6 4.3 3.1 2.5 1.9 6.6 4.3 4.9

FDC Profit & Loss

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 773 846 889 994 1014 1075 1091 1344 1333 1528 1784 1915
Other Income 46 42 46 39 50 51 43 69 97 76 51 88
Total Income 819 888 935 1033 1064 1126 1134 1413 1430 1604 1835 2005
Total Expenditure 592 641 691 766 770 848 860 1051 999 1274 1534 1584
Operating Profit 227 246 244 268 294 278 274 362 431 330 301 419
Interest 2 3 2 1 1 1 1 3 3 3 4 4
Depreciation 28 25 39 34 35 35 33 37 38 37 39 40
Exceptional Income / Expenses 0 0 0 0 -6 0 -1 0 -2 0 0 0
Profit Before Tax 198 218 204 232 252 241 237 320 388 289 258 377
Provision for Tax 43 83 56 63 63 67 67 80 87 73 64 86
Profit After Tax 155 135 148 169 189 174 170 240 301 216 194 290
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 155 135 148 169 189 174 170 240 301 216 194 290
Adjusted Earnings Per Share 8.6 7.6 8.3 9.5 10.6 9.9 9.7 14 17.9 12.8 11.7 17.7

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 17% 10% 11% 9%
Operating Profit CAGR -9% -6% 2% 3%
PAT CAGR -10% -7% 2% 2%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 44% 10% 22% 13%
ROE Average 10% 13% 14% 15%
ROCE Average 13% 18% 18% 21%

FDC Balance Sheet

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds 784 845 936 1082 1270 1276 1445 1547 1734 1957 1982
Minority's Interest 0 0 0 0 0 0 0 0 -0 -0 -1
Borrowings 1 1 1 1 1 1 0 0 1 1 1
Other Non-Current Liabilities 30 30 23 19 216 211 229 314 299 391 468
Total Current Liabilities 154 196 188 163 389 480 497 565 622 690 730
Total Liabilities 970 1072 1148 1266 1876 1968 2172 2427 2655 3038 3180
Fixed Assets 289 284 393 675 678 674 682 674 689 705 699
Other Non-Current Assets 270 336 253 67 280 303 431 508 614 914 1036
Total Current Assets 411 452 502 523 918 991 1058 1245 1348 1418 1443
Total Assets 970 1072 1148 1266 1876 1968 2172 2427 2655 3038 3180

FDC Cash Flow

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 24 4 23 12 16 27 28 20 30 30 38
Cash Flow from Operating Activities 150 150 128 174 154 150 112 250 207 162 155
Cash Flow from Investing Activities -107 -55 -89 -73 -144 20 -120 -98 -77 -145 11
Cash Flow from Financing Activities -63 -75 -48 -97 0 -169 -0 -142 -129 -10 -180
Net Cash Inflow / Outflow -20 19 -9 4 11 1 -8 10 1 7 -14
Closing Cash & Cash Equivalent 4 23 15 16 27 28 20 30 30 38 24

FDC Ratios

# Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) 8.58 7.61 8.33 9.48 10.6 9.95 9.74 14.03 17.85 12.82 11.7
CEPS(Rs) 10.12 9.01 10.51 11.38 12.55 11.96 11.64 16.22 20.08 15.01 14.03
DPS(Rs) 2.25 2.25 2.25 2.25 2.25 0 0 0.8 0 0 0
Book NAV/Share(Rs) 43.33 47.5 52.62 60.87 71.42 73.17 82.86 90.51 102.73 115.92 119.47
Core EBITDA Margin(%) 22.94 23.69 21.86 22.48 23.17 20.36 20.61 21.25 24.46 16.12 13.57
EBIT Margin(%) 25.28 25.67 22.62 22.96 24.1 21.74 21.24 23.45 28.65 18.59 14.24
Pre Tax Margin(%) 25.07 25.31 22.42 22.82 23.96 21.61 21.11 23.21 28.4 18.39 14.02
PAT Margin (%) 19.68 15.69 16.31 16.58 17.94 15.59 15.15 17.4 22.06 13.74 10.54
Cash Profit Margin (%) 23.22 18.58 20.58 19.89 21.23 18.74 18.11 20.12 24.83 16.11 12.66
ROA(%) 16.92 13.26 13.34 13.97 12 9.03 8.2 10.43 11.85 7.59 6.23
ROE(%) 20.99 16.62 16.64 16.72 16.03 13.63 12.48 16.03 18.36 11.71 9.84
ROCE(%) 26.84 27.1 23.02 23.11 21.51 19 17.49 21.56 23.74 15.78 13.25
Receivable days 19.72 21.7 24.19 22.06 23.96 25.86 27.55 27.96 31.31 22.35 20.32
Inventory Days 46.9 42.89 45.45 45.58 46.55 48.79 54.43 50.8 56.79 60.27 62.83
Payable days 83.52 96.74 111.83 86.56 84.88 89.37 92.5 83.79 86.01 73.73 87.78
PER(x) 10.74 16.55 18.2 19.53 19.25 25.3 17.21 13.97 16 20.04 21.94
Price/Book(x) 2.13 2.65 2.88 3.04 2.86 3.44 2.02 2.17 2.78 2.22 2.15
Dividend Yield(%) 2.44 1.79 1.48 1.21 1.1 0 0 0.41 0 0 0
EV/Net Sales(x) 2.11 2.62 3.02 3.3 3.55 4.06 2.66 2.47 3.6 2.82 2.38
EV/Core EBITDA(x) 7.19 9.01 10.99 12.24 12.26 15.71 10.57 9.19 11.13 13.06 14.09
Net Sales Growth(%) 8.77 9.45 5.14 11.81 1.97 6.04 1.45 23.24 -0.82 14.61 16.74
EBIT Growth(%) 14.81 11.11 -7.22 13.67 8.43 -4.42 -1.64 35.83 20.96 -25.23 -10.46
PAT Growth(%) 15.72 -12.79 9.48 13.86 11.77 -7.97 -2.14 41.28 25.56 -28.23 -10.33
EPS Growth(%) 17.06 -11.32 9.48 13.86 11.77 -6.16 -2.14 44.12 27.23 -28.19 -8.77
Debt/Equity(x) 0 0 0 0 0 0 0 0 0 0 0
Current Ratio(x) 2.67 2.31 2.67 3.2 2.36 2.06 2.13 2.21 2.17 2.05 1.98
Quick Ratio(x) 2.02 1.78 2.02 2.4 2.02 1.74 1.78 1.83 1.82 1.61 1.53
Interest Cover(x) 124.23 71.41 113.3 166.77 179.64 172.28 165.52 94.66 113.9 94.67 64.07
Total Debt/Mcap(x) 0 0 0 0 0 0 0 0 0 0 0

FDC Shareholding Pattern

# Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Promoter 69.36 69.36 69.5 69.5 69.5 69.5 69.5 69.66 69.66 69.66
FII 4.47 4.52 4.34 3.99 3.77 3.8 2.06 2.42 2.43 2.65
DII 5.45 5.86 6.08 6.77 7.76 8.27 9.12 8.12 7.76 6.94
Public 20.72 20.27 20.09 19.74 18.98 18.43 19.32 19.8 20.15 20.76
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Company is almost debt free.

Cons

  • Company has a low return on equity of 13% over the last 3 years.
  • Debtor days have increased from 73.73 to 87.78days.
  • Stock is trading at 3.5 times its book value.
  • The company has delivered a poor profit growth of 2% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

FDC News

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!